Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | quality defensive · low |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | ~$58 (≈ -25% vs spot) — precision reflects LOW valuation confidence |
| 12-mo scenario PWEV | ~$78 (≈ +0% vs spot) |
| Next catalyst | 2026-09-15 — Renewable diesel / biofuel policy (RVO, 45Z credit) decision window |
| Primary thesis-break | Ag Services & Oilseeds segment operating profit (YoY) < -0.2 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · quality defensive · analyst conviction: low
| Metric | Value |
|---|---|
| Current Price | $78.16 |
| Triangulated Fair Value | $58.33 (-25% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $78.22 (+0% vs spot · 12m PWEV) |
| Forward P/E | 17.0x |
| Market Cap | $38B |
| 52-Week Range | $50.07–$86.76 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — an intrinsic DCF, a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 43.3/100 (8th pct) | +0% 1yr expected | Hold | Covered Call | 21d — Renewable diesel / biofuel policy (RVO, 45Z credit) decision window |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $58.33 (-25% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.
Investment Thesis
At $78.16 (25 August 2026) ADM trades on 17 times forward earnings, a premium to its agricultural-processing peer median. The market is paying for normalised crush and protein margins persisting, and giving credit for the cost and portfolio discipline management has promised. The engine is less generous. Roughly two-fifths of the scenario weight sits on margin-reset or trough paths, and fewer than half of simulated outcomes finish above spot. The razor-thin operating margin of 2.5% on a very large revenue base leaves modest free cash after capital spending, so much of the equity case rests on the multiple rather than on cash generation, and the discounted-cash-flow work lands far under the market price. Triangulated fair value of $58.33 leaves the shares trading rich to the anchor set, -25% against spot, while the probability-weighted value of $78.22 and the base-path target of $78.37 sit just below the price against net debt of ~$10.1B. The rating is HOLD. The single most damaging risk is a structural crush-capacity overbuild, whose target sits below the 52-week low.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($78.16) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The bear mechanism is capacity, not demand. North and South American soybean crush capacity has been built out on renewable-diesel expectations; if biofuel policy support softens while the new plants keep running, crush margins reset structurally rather than cyclically. ADM earns only a few cents of operating profit per revenue dollar — an operating margin of 2.5% — so a modest margin reset removes a large fraction of earnings, and the market will not sustain a 17 times multiple on a processor it has reclassified as structurally impaired while it carries net debt of ~$10.1B. Nutrition has not delivered its promised diversification, and the intersegment-accounting episode gives sceptics grounds to discount reported segment margins altogether. On those drivers the structural scenario compresses earnings and multiple together, below the 52-week low.
Key Debate
Gross Margin explains 68% of Monte Carlo outcome variance — the single variable that decides which side is right.
What the Market Is Pricing In
At the current price, the market pays 14.4× consensus forward EPS, vs the house DCF terminal 14.0×, and a peer median 14.4×. The house DCF sits 50% below spot, so the market is pricing in more than the house case — roughly 3.4pp of revenue CAGR.
Variant perception: the house view is in-line with consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 84.4 | 82.2 | High |
| EPS | 5.4 | 4.6 | Medium |
| Target price | 78.7 | 78.4 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Crush / Protein Margin Reset' downside ($28.20) to a 'Spike — Supply Dislocation' bull case ($155); the probability-weighted blend (PWEV $78.22) is +0% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $28.20 | -64% |
| Cyclical Margin Trough | 18% | $48.20 | -38% |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $79.60 | +2% |
| Upcycle — Tight Margins | 20% | $127 | +63% |
| Spike — Supply Dislocation | 8% | $155 | +98% |
| Probability-Weighted (PWEV) | — | $78.22 | +0% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.1% of revenue; free cash flow net of SBC is $4.12B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Crush / Protein Margin Reset (22%, $28.20). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Cyclical Margin Trough (18%, $48.20). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising.
- Base — Mid-Cycle Crush / Protein Margins (32%, $79.60). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns.
- Upcycle — Tight Margins (20%, $127). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly.
- Spike — Supply Dislocation (8%, $155). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins.
Valuation Triangulation
Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $69.65 | -11% | 20% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $228 | +191% | 0% — cross-check only |
| Scenario PWEV | multiple | $78.22 | +0% | 33% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $39.28 | -50% | 47% (declared 35%) |
| Triangulated (weighted) | — | $58.33 | -25% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $69.65 + scenario PWEV $78.22, ≈ spot); the weighted blend $58.33 (-25%) sits below it because the cash-flow DCF ($39.28) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $69.65 and 43% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (68% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 14.0x terminal FCF multiple → $39.28. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $228; the peer-median forward P/E is 14.4x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 241% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 9.8x | 11.9x | 14.0x | 16.1x | 18.2x |
|---|---|---|---|---|---|
| 7.0% | $30.39 | $37.38 | $44.36 | $51.35 | $58.34 |
| 8.0% | $28.42 | $35.08 | $41.75 | $48.42 | $55.09 |
| 9.0% | $26.54 | $32.91 | $39.28 | $45.65 | $52.02 |
| 10.0% | $24.76 | $30.85 | $36.93 | $43.02 | $49.10 |
| 11.0% | $23.07 | $28.89 | $34.70 | $40.52 | $46.33 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-15.88 | $7.75 | $31.39 | $55.03 | $78.67 |
| -1.5pp | $-15.25 | $9.99 | $35.23 | $60.46 | $85.70 |
| +0.0pp | $-14.58 | $12.35 | $39.28 | $66.21 | $93.14 |
| +1.5pp | $-13.87 | $14.85 | $43.56 | $72.28 | $101 |
| +3.0pp | $-13.12 | $17.48 | $48.09 | $78.69 | $109 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $-15.00 | $93.00 | $108 |
| Revenue CAGR ±3pp | $31.00 | $48.00 | $17.00 |
| Terminal × ±15% | $33.00 | $46.00 | $13.00 |
| Capex intensity ±15% | $33.00 | $46.00 | $13.00 |
| WACC ±1pp | $37.00 | $42.00 | $5.00 |
Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 17.0x)
| Multiple | 11.9x | 14.4x | 17.0x | 19.5x | 22.1x |
|---|---|---|---|---|---|
| SoP/share | $29.00 | $39.00 | $50.00 | $61.00 | $71.00 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| BG | 14.5× | 2% | 1% | direct | 100% |
| KVUE | 16.5× | 4% | 22% | direct | 100% |
| KR | 11.2× | 5% | 3% | segment | 50% |
| KMB | 14.2× | 4% | 20% | direct | 100% |
Quality-weighted forward P/E: 14.5× (simple median 14.4×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $50.07–$86.76, centre $65.90 (-16% vs spot); spot sits at the 77th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $58.33 (-25% vs spot · triangulated FV) |
| Downside to bear case (Structural — Crush / Protein Margin Reset) | $28.20 (-64% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -34% |
| P(price > spot) — Monte Carlo | 43% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Spike — Supply Dislocation): $155.
Company Overview & Business Model
Archer-Daniels-Midland Company — CONSUMER DEFENSIVE · FARM PRODUCTS. The Archer-Daniels-Midland Company, commonly known as ADM, is an American multinational food processing and commodities trading corporation founded in 1902 and headquartered in Chicago, Illinois. The company operates more than 270 plants and 420 crop procurement facilities worldwide, where cereal grains and oilseeds are processed into products used in food, beverage, nutraceutical, industrial, and animal feed markets worldwide.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Agricultural Products & Protein | 100% | +2% | 2% | ag-processing crush margins / protein cycle + commodity & feed costs |
Edge. Narrow moat — ADM's advantage is scale in origination, logistics and crush capacity, not pricing power; margins are set by the crush/protein spread, not the franchise. FALSIFIABLE: if trailing crush margins mean-revert to mid-cycle and ROIC fails to exceed WACC across a full cycle, the terminal multiple should sit at or below the commodity-processor ~13-14x, not a premium.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Agricultural Products & Protein | $80.6B | 100% | 2% | 2% | $2.0B | 17.0x | 6% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | ag-processing crush margins / protein cycle + commodity & feed costs |
| net_debt_or_cash_b | -10.07 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.06 |
| div_yield | 0.0273 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | crush / protein margin reset |
| upside | tight crush / protein margins |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $8.7B — levered |
| Net debt / EBITDA | 2.91x |
| Interest coverage (EBIT / interest) | 3.0x |
| Current ratio | 1.37x |
| Lease obligations | $1.3B |
| Cash & ST investments | $1.0B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $4.2B |
| Buybacks / dividends | $0.0B / $1.0B |
| Total shareholder yield | 2.6% |
| Payout as % of FCF | 23.5% |
| Reinvestment (capex / OCF) | 22.9% |
| SBC as % of FCF | 2.0% |
| Allocation stance | reinvesting |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 5.2% |
| FCF conversion (FCF / net income) | 391.8% |
| FCF yield | 11.1% |
| Capex intensity (capex / revenue) | 1.5% |
| FCF − SBC (diagnostic) | $4.1B |
| Capex split (maint / growth) | 65% / 35% — Capital runs ~1.5% of revenue under a cost-discipline programme; the bulk is maintenance/turnaround on crush plants, elevators and logistics assets, with a minority for Nutrition capacity and de-bottlenecking. |
Accounting quality: SBC 1% of revenue.
Competitive Moat
Moat sources:
- Global grain origination and logistics network (barges, elevators, ports) - hard to replicate but low margin
- Crush capacity scale in soy/corn - cost advantage, not price-setting power
- Nutrition segment brand/formulation IP (the only genuine margin franchise, still small)
- No durable pricing power: margins are spread-driven and mean-reverting
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.55 vs analyst floor +0.11 → delta +0.44 (n=18 mgmt / 11 Q&A; 58th pctile across the S&P book, z +0.2).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.55 | +0.11 | +0.44 |
| 2026Q1 | +0.43 | +0.05 | +0.38 |
| 2025Q4 | +0.21 | +0.06 | +0.14 |
| 2025Q3 | +0.35 | +0.17 | +0.18 |
News (last 365d, 1379 articles): avg ticker sentiment +0.14 (bullish 18% / bearish 5%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $78.70 (+1% vs spot · street) |
| House target | $78.37 (-0.4% vs street) |
| Sell-side coverage | 11 analysts (SB 0 / B 1 / H 7 / S 1 / SS 2; net score -0.18) |
| Consensus FY EPS | $5.42 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $84.4B; house in-line (-2.6%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-09-15 (~22d) — Renewable diesel / biofuel policy (RVO, 45Z credit) decision window (authored)
- 2027-01-12 (~141d) — Nutrition segment restructuring / portfolio update (authored)
Forecast Track Record
- EPS surprise: beat 62% of the last 8 quarters; average surprise +8.1%.
- Prior-forecast backtest (12 snapshots, 2026-06-26→2026-08-20): directional hit-rate 92%; mean predicted -2.5% vs realised -2.7%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
5 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-15 (in 21d) | Renewable diesel / biofuel policy (RVO, 45Z credit) decision window | authored | ● | 0.7 |
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-12 (in 140d) | Nutrition segment restructuring / portfolio update | authored | ● | 0.7 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 297d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| US biofuel policy (Renewable Volume Obligations, 45Z clean-fuel credit) driving soybean-oil demand and crush economics | high (~60%) | high - crush spread is the core earnings driver; a policy swing is ~10-15% of FV | 12-24m |
| SEC / accounting scrutiny follow-through on the prior Nutrition-segment intersegment accounting restatement | medium (~30%) | medium - governance discount and potential penalties ~3-6% of FV | 12-24m |
| Agricultural tariffs / export restrictions (China soy, retaliatory measures) disrupting trade flows | medium (~35%) | medium - reroutes flows and compresses origination margins ~4-7% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Crush / Protein Margin Reset | Global crush and protein capacity additions plus soft biofuel demand permanently compress spreads back toward long-run lows; the market re-rates ADM to a commodity-trough multiple. | Spreads reset AND Nutrition fails to grow, leaving ROIC below WACC through the cycle. |
| Cyclical Margin Trough | A cyclical low in crush/protein margins driven by ample harvests and weak export demand squeezes segment profitability for several quarters. | The trough coincides with high working-capital costs, straining free cash and dividend cover. |
| Upcycle — Tight Margins | Tight crush/protein spreads from strong biofuel-driven soybean-oil demand and firm protein prices lift segment margins above trend. | Tight-margin windows are short-lived and reverse quickly once capacity or harvest normalizes. |
| Spike — Supply Dislocation | A weather- or geopolitics-driven supply dislocation (drought, export ban, trade shock) spikes spreads and origination margins for a few quarters. | Spikes are non-recurring and can invert into inventory losses when prices reverse. |
Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
0.27 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
0.27 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
-0.18 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
no data | — |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.12 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
1.1 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Ag Services & Oilseeds segment operating profit (YoY) < -0.2 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Companywide operating margin (segment operating profit / revenue) < 0.03 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Revenue growth (YoY) < -0.005 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Operating cash flow, trailing four quarters ($B) < 2.3 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- New material accounting restatement or SEC enforcement action on segment reporting (count) >= 1 (single event). The 2024 intersegment-pricing investigation forced a restatement and removed the CFO. A recurrence would impair confidence in reported segment economics and maps directly to the multiple-compression leg of the structural scenario.
Fact / Inference / Speculation
- FACT: Spot $78.16; 52-week range $50.07–$86.76; engine rating HOLD; house target $78.37 (+0%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $58.33 (-25% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
43.3/100 (confidence band 32.7–53.8), 8th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 27 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 29 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 50 | 15% | upside_pct |
| growth | 45 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 62 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 46 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 54 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 37 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 45.2 → 45.2 → 45.0 → 44.9 → 44.9 → 45.4 → 46.0 → 46.0.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $28.20 | -63.9% | -14.1pp |
| Cyclical Margin Trough | 18% | $48.20 | -38.3% | -6.9pp |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $79.60 | +1.8% | +0.6pp |
| Upcycle — Tight Margins | 20% | $127 | +63.0% | +12.6pp |
| Spike — Supply Dislocation | 8% | $155 | +98.1% | +7.8pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +0.1% |
| Expected return net of SBC dilution | +0.1% |
| Outcome dispersion (σ, from MC p10–p90) | 67.5% |
| Expected Sharpe (rf 4%) | -0.06 |
| Downside expectation (prob-weighted loss branches) | -21.0% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 0.1% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 0.34 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 5.5% |
| Expected alpha | -5.4% |
| Alpha per unit risk (EA/σ) | -0.08 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 52.2% (1σ) | 24.5% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 60.0% | 43.2% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $78.22.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 2 | AI | 32 | |
| Value | 20 | Cloud | 18 | |
| Quality | 10 | Semis | 37 | |
| Momentum | 87 | Consumer | 4 | |
| Low-Vol | 68 | Rates | 6 | |
| USD | 85 | |||
| Energy | 95 |
Market interaction: correlation vs SPY +0.16, vs QQQ +0.08 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
- Direction neutral from the overlay conviction/rating (read-only input).
- IV/RV at the 78th percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 67th percentile of its own month-end history (decile 7).
- IV term structure is in contango (longer-dated richer, slope +2.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +2.9pp): 25-DTE 31% · 88-DTE 35% · 389-DTE 34%
| Priced structure | Value |
|---|---|
| Legs | Short 82.5 C |
| Expiry | 2026-09-18 |
| Income yield | 1.3% |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.15% NAV |
| Annualized outcome σ (MC) | 67.5% |
| Indicative holding period | 6–18 months |
| Liquidity | high, ~$330M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 30.8% (elevated regime) · expected move ±6.4% (2026-09-18) · put/call OI 0.50 · ATM Δ 0.57 / Θ -0.05 / ν 0.08. Direction: NEUTRAL (implied return -25.4% to triangulated fair value $58.33).
Covered Call (if held) (Income / neutral) — Short 82.5 C · 2026-09-18 · premium $1.0 · yield 1.3% · priced from the listed chain (EOD marks)
Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Elevated implied volatility currently enriches the premium collected. Illustrative — no outcome is implied or guaranteed.
Put Spread (income) (Income / would-own) — Short 72.5 P / Long 65 P · 2026-10-16 · net $1.03 · net entry $71.47 · yield 1.4% · RoR 16.0% · max loss $6.47 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Protective Collar (if held) (Hedge) — Long 70 P / Short 85 C · 2027-03-19 · net $1.4 · floor -10.0% · cap +9.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +0% vs spot
- Monte Carlo median implies -11% vs spot
- DCF fair value implies -50% vs spot
- Bear case (Structural — Crush / Protein Margin Reset) downside is -64% vs spot
- Net: the valuation anchor itself sits 25.4% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $82B | $3B | $1B | $1B | $2B | $2B |
| FY+2 | $84B | $3B | $1B | $1B | $2B | $2B |
| FY+3 | $85B | $3B | $2B | $1B | $2B | $2B |
| FY+4 | $86B | $3B | $2B | $1B | $2B | $2B |
| FY+5 | $86B | $3B | $2B | $1B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 14.0x | $21B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $9B + PV(terminal) $21B = EV $29B; − net debt $10.1B → equity $19B ÷ diluted shares $0.48B = $39.28/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $44.64/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 3% vs WACC 9.0% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| BG | 0.5x | 14.5x | 2% | 1% |
| KVUE | 2.9x | 16.5x | 4% | 22% |
| KR | 0.4x | 11.2x | 5% | 3% |
| KMB | 2.5x | 14.2x | 4% | 20% |
| Median | 1.5x | 14.4x | — | — |
Implied prices at the peer medians: EV/Rev → $228 (no P/E-implied price — no forward-EPS basis at the peer step).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $39.28 | 47% | $18.33 |
| Scenario PWEV | $78.22 | 33% | $26.07 |
| Monte Carlo median | $69.65 | 20% | $13.93 |
| Triangulated | — | 100% | $58.33 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 9.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 14× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (108.0); Revenue CAGR ±3pp (17.0); Terminal × ±15% (13.0); Capex intensity ±15% (13.0); WACC ±1pp (5.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $80.6B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $82.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $5.4161 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.484B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $8.711B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 9.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 14× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 9.0%, terminal multiple 14×, FY+5 revenue $86B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.